Dose accumulation for MR-guided adaptive radiotherapy: From practical considerations to state-of-the-art clinical implementation
Frontiers in Oncology · 26.01.2023 · 12
DOI: 10.3389/fonc.2022.1086258 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 26.01.2023. Verfasst von Brigid A McDonald und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDCR NIH HHS, NIBIB NIH HHS.
Abstract (Originalsprache)
MRI-linear accelerator (MR-linac) devices have been introduced into clinical practice in recent years and have enabled MR-guided adaptive radiation therapy (MRgART). However, by accounting for anatomical changes throughout radiation therapy (RT) and delivering different treatment plans at each fraction, adaptive radiation therapy (ART) highlights several challenges in terms of calculating the total delivered dose. Dose accumulation strategies—which typically involve deformable image registration between planning images, deformable dose mapping, and voxel-wise dose summation—can be employed for ART to estimate the delivered dose. In MRgART, plan adaptation on MRI instead of CT necessitates additional considerations in the dose accumulation process because MRI pixel values do not contain the quantitative information used for dose calculation. In this review, we discuss considerations for dose accumulation specific to MRgART and in relation to current MR-linac clinical workflows. We present a general dose accumulation framework for MRgART and discuss relevant quality assurance criteria. Finally, we highlight the clinical importance of dose accumulation in the ART era as well as the possible ways in which dose accumulation can transform clinical practice and improve our ability to deliver personalized RT.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
- Department of Radiotherapy, University Medical Center Utrecht, Utrecht, Netherlands.
- Elekta AB, Stockholm, Sweden.
- Department of Radiation Oncology, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
- Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
- Section for Biomedical Physics, Department of Radiation Oncology, University of Tuebingen, Tuebingen, Germany.
Förderung
- NCI NIH HHS
- NIDCR NIH HHS
- NIBIB NIH HHS
- National Institute of Dental and Craniofacial Research
Zitieren
APA
McDonald, B. A., Zachiu, C., Christodouleas, J., Naser, M. A., Ruschin, M., Sonke, J. J., Thorwarth, D., Létourneau, D., Tyagi, N., Tadic, T., Yang, J., Li, X. A., Bernchou, U., Hyer, D. E., Snyder, J. E., Bubula-Rehm, E., Fuller, C. D., & Brock, K. K. (2023). Dose accumulation for MR-guided adaptive radiotherapy: From practical considerations to state-of-the-art clinical implementation. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.1086258
Vancouver
McDonald BA, Zachiu C, Christodouleas J, Naser MA, Ruschin M, Sonke JJ, et al. Dose accumulation for MR-guided adaptive radiotherapy: From practical considerations to state-of-the-art clinical implementation. Frontiers in Oncology. 2023;12. doi:10.3389/fonc.2022.1086258
BibTeX
@article{McDonald2023,
author = {McDonald, Brigid A and Zachiu, Cornel and Christodouleas, John and Naser, Mohamed A and Ruschin, Mark and Sonke, Jan-Jakob and Thorwarth, Daniela and Létourneau, Daniel and Tyagi, Neelam and Tadic, Tony and Yang, Jinzhong and Li, X Allen and Bernchou, Uffe and Hyer, Daniel E and Snyder, Jeffrey E and Bubula-Rehm, Edyta and Fuller, Clifton D and Brock, Kristy K},
title = {Dose accumulation for MR-guided adaptive radiotherapy: From practical considerations to state-of-the-art clinical implementation},
journal = {Frontiers in Oncology},
year = {2023},
volume = {12},
doi = {10.3389/fonc.2022.1086258}
}
EUVIMED